What is the significance of monoclonal gammopathy of undetermined significance?
Catherine Atkin, Alex Richter and Elizabeth Sapey
DOI: https://doi.org/10.7861/clinmedicine.18-5-391
Clin Med October 2018 Catherine Atkin
AInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Roles: clinical research fellow
Alex Richter
BInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Roles: senior lecturer and consultant in clinical immunology
Elizabeth Sapey
CInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
Roles: reader and consultant in respiratory medicine
Article Tools
What is the significance of monoclonal gammopathy of undetermined significance?
Catherine Atkin, Alex Richter, Elizabeth Sapey
Clinical Medicine Oct 2018, 18 (5) 391-396; DOI: 10.7861/clinmedicine.18-5-391
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
- Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
- The challenge of change: evidence, culture and expertise